SCHEMBL7767952

SCHEMBL7767952

CC1COCCN1c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 16/20 0.54
MTOR P42345 3/20 0.48
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27320448 1.00 PIK3C3 (0.54) PIK3C3MTORLMNA
SCHEMBL27318560 1.00 PIK3C3 (0.54) PIK3C3MTORLMNA
SCHEMBL21256945 0.84 PIK3C3 (0.50) PIK3C3MTOR
SCHEMBL26515061 0.84 PIK3C3 (0.50) PIK3C3MTOR
SCHEMBL25222723 0.82 PIK3C3 (0.49) PIK3C3
SCHEMBL24681517 0.82 MTOR (0.50) PIK3C3MTOR
SCHEMBL22296389 0.82 PIK3C3 (0.49) PIK3C3
SCHEMBL24681530 0.82 MTOR (0.50) PIK3C3MTOR
SCHEMBL22296387 0.82 PIK3C3 (0.49) PIK3C3
SCHEMBL16611301 0.82 PIK3C3 (0.49) PIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120040747-A Flame-retardant silane modified polyether resin and preparation method thereof 传辰立新(厦门)科技有限公司 2025-05-27 CN claimed
CN-120040747-A Flame-retardant silane modified polyether resin and preparation method thereof 传辰立新(厦门)科技有限公司 2025-05-27 CN disclosed
CN-113072460-B Morpholine derivative oxidation ring-opening method and product thereof 西南大学 2022-06-24 CN disclosed
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed
CN-113072460-A Morpholine derivative oxidation ring-opening method and product thereof 西南大学 2021-07-06 CN disclosed
EP-3689871-A1 4,6,7-TRISUBSTITUTED 1,2-DIHYDROPYRROL[3,4-C]PYRIDIN/PYRIMIDIN-3-ONE DERIVATIVE AND USE Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (CN) 2020-08-05 EP disclosed
EP-0740690-B1 MONOAZO DYES CONTAINING A FLUOROSULPHONYL GROUP AND USE THEREOF SYNGENTA LTD (GB) 2001-06-20 EP disclosed
US-5739299-A GOOD WET FASTNESS AND LIGHT FASTNESS PROPERTIES ZENECA LIMITED (GB) 1998-04-14 US disclosed
EP-0740690-A1 MONOAZO DYES CONTAINING A FLUOROSULPHONYL GROUP AND USE THEREOF ZENECA LIMITED (GB) 1996-11-06 EP disclosed
WO-1995020014-A1 MONOAZO DYES CONTAINING A FLUOROSULPHONYL GROUP AND USE THEREOF ZENECA LIMITED (GB) 1995-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G PIK3C3 1657/4885MTOR 505/4885LMNA 3715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.